UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

SEC File Number: 000-51060

CUSIP Number: 169398104

(Check one):	¨ Form 10-K    ¨  Form 20-F    ¨ Form 11-K    þ  Form 10-Q    ¨  Form 10-D    ¨  Form N-SAR    ¨  Form N-CSR
	For the Period Ended:	December 31, 2013
	¨  Transition Report on Form 10-K
	¨  Transition Report on Form 20-F
	¨  Transition Report on Form 11-K
	¨  Transition Report on Form 10-Q
	¨  Transition Report on Form N-SAR
	For the Transition Period Ended:

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I — REGISTRANT INFORMATION

China Health Industries Holdings, Inc.

Full Name of Registrant

N/A

Former Name if Applicable

168 Binbei Street, Songbei District

Address of Principal Executive Office (Street and Number)

Harbin City, Heilongjiang Province, People’s Republic of China 150028

City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

	(a)	The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
þ	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
	(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III — NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

On November 22, 2013, China Health Industries Holdings, Inc. (the “Company”), through its wholly owned subsidiary Harbin Humankind Biology Technology Co., Limited, completed the acquisition of Heilongjiang Huimeijia Pharmaceutical Co., Ltd.. As a result, the Company has encountered a delay in assembling the information required to be included in its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2013.

In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, as amended, the Company endeavors to file its Quarterly Report on Form 10-Q no later than February 19, 2014, five calendar days following February 14, 2014, the prescribed due date.

PART IV — OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Xin Sun, Chief Executive Officer	(86)	451-88100688
(Name)	(Area Code)	(Telephone Number)

(2)	Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
Yes þ     No ¨

(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
Yes ¨     No þ

CHINA HEALTH INDUSTRIES HOLDINGS, INC.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Date:  February 18, 2014	By:	/s/ Xin Sun
	Name:	Xin Sun
	Title:	Chief Executive Officer